Optogenetic BNST Neuron Control for Anxiety
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods are unable to causally test how specific diverging projections recruit distinct features to assemble a behavioral state, particularly in modulating anxiety, due to the lack of temporal precision in controlling nervous system outputs in intact biological systems.
Innovation Solution
The use of light-responsive polypeptides, such as those with amino acid sequences similar to SEQ ID NOs:5-11, expressed in BNST neurons and activated by specific wavelengths of light to modulate anxiety-related behaviors by inhibiting or activating BNST neurons, thereby reducing risk avoidance, respiratory rate, or other anxiety-related features.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Measurement precision
If conventional methods are used to control nervous system outputs, then the system can be operated without specialized tools, but the temporal precision required to keep pace with functioning biological systems is not achieved
Solution Approach 1:
The patent replaces conventional electrical or chemical stimulation methods with optogenetic control using light-responsive opsins. This substitution enables millisecond-timescale temporal precision by using optical signals to control neuronal activity, directly addressing the need for precise temporal control while maintaining compatibility with intact biological systems.
Solution Approach 2:
The patent introduces light-responsive opsin proteins as intermediaries between light stimuli and neuronal activity. These opsins act as mediators that convert optical signals into electrical responses in targeted neurons, enabling precise temporal control of nervous system outputs without directly applying electrical or chemical stimuli to the complex neural circuitry.
2Loss of information
If specific diverging projections are targeted to test causal recruitment of behavioral features, then behavioral state assembly can be understood, but the complexity of targeting specific neuronal projections increases
Solution Approach 1:
The patent applies local quality by expressing light-responsive opsins in specific neuronal populations or projection types within the BNST using targeted viral delivery or genetic approaches. This allows selective control of particular diverging projections (e.g., to different hypothalamic nuclei) while leaving other neural circuits unaffected, enabling causal testing of how specific projections recruit distinct behavioral features.
Solution Approach 2:
The patent segments the BNST into functionally distinct subnuclei and projection types, each with unique opsin expression patterns. This segmentation allows independent manipulation and testing of specific neural circuits (e.g., adBNST projections to LH versus PB) that contribute to different aspects of anxiety and defensive behavior, thereby understanding how diverse features are assembled into coherent behavioral states.
3Reliability
If BNST neuron activity is modulated to reduce anxiety features, then anxiety-related behaviors are reduced, but the specificity of modulating individual anxiety features (risk avoidance versus respiratory rate) becomes challenging
Solution Approach 1:
The patent uses local quality by targeting opsin expression to specific BNST subnuclei (e.g., adBNST versus ovBNST) or specific projection types (e.g., projections to LH versus PB versus VTA). This spatial specificity enables selective modulation of particular anxiety features: adBNST-LH projections for risk avoidance, adBNST-PB projections for respiratory rate, thereby achieving feature-specific control while maintaining reliable anxiety reduction.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
This approach allows for precise modulation of anxiety features in subjects by activating or inhibiting BNST neurons, effectively reducing anxiety-related behaviors and respiratory rates, providing a method to identify candidate agents for treating anxiety disorders.
Implementation Method 1
exposing the anterodorsal BNST neuron to light of an activating wavelength
Data Source
Figure 1
Figure 2
Figure 3
AI summary
The present disclosure provides methods of modulating a feature of a behavioral state. The methods involve inhibiting or activating the activity of a bed nucleus of stria terminalis (BNST) neuron, a BNST subnucleus, or a neuronal output to or from a BNST neuron. Animals encounter environmental conditions that require rapid switching among different behavioral states to increase the likelihood of survival and reproduction.